Charles Schwab’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.7M | Sell |
715,153
-12,271
| -2% | -$267K | ﹤0.01% | 1846 |
|
|
2025
Q4 | $15.3M | Buy |
727,424
+8,390
| +1% | +$146K | ﹤0.01% | 1914 |
|
|
2025
Q3 | $11.1M | Buy |
719,034
+6,724
| +0.9% | +$88K | ﹤0.01% | 2067 |
|
|
2025
Q2 | $6.67M | Buy |
712,310
+22,617
| +3% | +$249K | ﹤0.01% | 2205 |
|
|
2025
Q1 | $8.47M | Sell |
689,693
-15,130
| -2% | -$213K | ﹤0.01% | 2029 |
|
|
2024
Q4 | $9.32M | Buy |
704,823
+8,876
| +1% | +$152K | ﹤0.01% | 2046 |
|
|
2024
Q3 | $13.4M | Buy |
695,947
+41,458
| +6% | +$857K | ﹤0.01% | 1898 |
|
|
2024
Q2 | $13.4M | Buy |
654,489
+19,282
| +3% | +$404K | ﹤0.01% | 1890 |
|
|
2024
Q1 | $15.1M | Buy |
635,207
+58,185
| +10% | +$1.3M | ﹤0.01% | 1770 |
|
|
2023
Q4 | $12.5M | Buy |
577,022
+70,555
| +14% | +$1.08M | ﹤0.01% | 1872 |
|
|
2023
Q3 | $7.35M | Buy |
506,467
+15,156
| +3% | +$287K | ﹤0.01% | 2078 |
|
|
2023
Q2 | $10.3M | Buy |
491,311
+21,145
| +4% | +$440K | ﹤0.01% | 1896 |
|
|
2023
Q1 | $9.93M | Buy |
470,166
+21,425
| +5% | +$533K | ﹤0.01% | 1879 |
|
|
2022
Q4 | $11.4M | Buy |
448,741
+63,620
| +17% | +$1.48M | ﹤0.01% | 1786 |
|
|
2022
Q3 | $9.26M | Buy |
385,121
+28,216
| +8% | +$633K | ﹤0.01% | 1882 |
|
|
2022
Q2 | $6.87M | Buy |
356,905
+15,601
| +5% | +$260K | ﹤0.01% | 2030 |
|
|
2022
Q1 | $5.93M | Buy |
341,304
+35,308
| +12% | +$595K | ﹤0.01% | 2200 |
|
|
2021
Q4 | $6.7M | Buy |
305,996
+3,469
| +1% | +$64.1K | ﹤0.01% | 2204 |
|
|
2021
Q3 | $5.78M | Buy |
302,527
+32,896
| +12% | +$548K | ﹤0.01% | 2303 |
|
|
2021
Q2 | $4.63M | Buy |
269,631
+38,698
| +17% | +$709K | ﹤0.01% | 2389 |
|
|
2021
Q1 | $5.16M | Buy |
230,933
+36,465
| +19% | +$824K | ﹤0.01% | 2290 |
|
|
2020
Q4 | $4.33M | Buy |
194,468
+10,900
| +6% | +$226K | ﹤0.01% | 2295 |
|
|
2020
Q3 | $2.71M | Buy |
183,568
+117,149
| +176% | +$1.79M | ﹤0.01% | 2382 |
|
|
2020
Q2 | $985K | Buy |
66,419
+10,661
| +19% | +$162K | ﹤0.01% | 2632 |
|
|
2020
Q1 | $612K | Buy |
55,758
+5,594
| +11% | +$52.5K | ﹤0.01% | 2643 |
|
|
2019
Q4 | $441K | Hold |
50,164
| – | – | ﹤0.01% | 2868 |
|
|
2019
Q3 | $375K | Hold |
50,164
| – | – | ﹤0.01% | 2909 |
|
|
2019
Q2 | $468K | Buy |
50,164
+12,947
| +35% | +$94.4K | ﹤0.01% | 2844 |
|
|
2019
Q1 | $196K | Buy |
37,217
+8,335
| +29% | +$47.5K | ﹤0.01% | 3026 |
|
|
2018
Q4 | $129K | Buy |
28,882
+4,700
| +19% | +$25.8K | ﹤0.01% | 3072 |
|
|
2018
Q3 | $196K | Sell |
24,182
-218
| -0.9% | -$1.55K | ﹤0.01% | 3079 |
|
|
2018
Q2 | $172K | Hold |
24,400
| – | – | ﹤0.01% | 3078 |
|
|
2018
Q1 | $348K | Hold |
24,400
| – | – | ﹤0.01% | 2835 |
|
|
2017
Q4 | $214K | Hold |
24,400
| – | – | ﹤0.01% | 2971 |
|
|
2017
Q3 | $286K | Buy |
24,400
+14,300
| +142% | +$175K | ﹤0.01% | 2888 |
|
|
2017
Q2 | $142K | Hold |
10,100
| – | – | ﹤0.01% | 3071 |
|
|
2017
Q1 | $139K | Hold |
10,100
| – | – | ﹤0.01% | 2978 |
|
|
2016
Q4 | $73K | Hold |
10,100
| – | – | ﹤0.01% | 3059 |
|
|
2016
Q3 | $154K | Hold |
10,100
| – | – | ﹤0.01% | 2966 |
|
|
2016
Q2 | $100K | Buy |
+10,100
| New | +$138K | ﹤0.01% | 3054 |
|
Other funds holding SNDX
KCM
VCM
DM
EP
KCM
HRCM